ScholarWorks@Korea University College of Medicine: Lee, Chang Kyu

Detailed Information

Lee, Chang Kyu (이창규)

Anam Hospital (Department of Laboratory Medicine, Anam Hospital)

Research Area

Tel 02-920-5381
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Influenza:5||respiratory virus:4||Korea:3||Respiratory virus:3||Blood culture:3||16S rRNA:3||Viral isolation:2||diabetes mellitus:2||diagnosis:2||Antibiotic therapy:2||Virus culture:2||fluconazole:2||Epidemiology:2||Diabetic foot:2||Rapid diagnostic test:2||Klebsiella pneumoniae:2||vector vaccine:2||mRNA vaccine:2||phylogenetic analysis:2||Microbiology:2||Culture:2||Plasmodium vivax:2||Republic of Korea:2||신빙도:2||Resistance:2||Pneumococci:2||Pneumonia:2||Surveillance:2||Respiratory tract infections:2||Carbapenemase:2||Evaluation:2||Carriage:2||Direct identification:2||SARSCoV2:2||Antimicrobial resistance:2||Oseltamivir:2||mixandmatch vaccine:2||Intensive care unit:2||Clostridium difficile:1||Coinfection.:1||Colonic bacteria:1||Color vision:1||Column agglutination method:1||ComboStick 10 strip:1||ComboStick Reader 720:1||Contrast sensitivity:1||Corynebacterium striatum:1||Coxsackievirus:1||CpG:1||Culture bottle:1||Cupriavidus:1||Cytomegalovirus:1||DNA:1||Dermabacter hominis:1||Diversion colitis:1||Etest:1||Efficacy:1||Electronic data interchange system:1||Emerging lineages:1||Enterobacter cloacae:1||Epidemiology 접 수 : 2006년 7월 14일 접수번호 :KJLM1971수정본접수 : 2006년 8월 4일:1||Epidermiology:1||Epigallocatechin gallate:1||Escherichia coli:1||Filtration:1||Fluorescent immunoassay:1||Formula:1||Fucosyltransferase II:1||Gastrointestinal Carriage:1||Genotype:1||Glomerular filtration rate:1||Google Glass:1||Gramnegative bacteria:1||Gramnegative bacterial infection:1||H1N1:1||HACEK bacteria:1||HBV quantitation:1||HLAB27 검사:1||Haemophilus influenzae:1||Haemophilus parainfluenzae:1||HbA1c:1||Hepatitis B:1||Hepatocyte Differentiation:1||Human parainfluenza virus 3:1||Hypervirulent:1||IFNalpha:1||IGRA:1||IL29:1||INR:1||Illumination:1||Imnnumocompromised host:1||Imunosuppression:1||Inhouse method:1||Infection control:1||Infective endocarditis:1||Influenza A/B:1||Internet:1||Interrupted timeseries analysis:1||JAK2:1||KPC2:1||Knee joint:1||LCMS:1||Legionnaires' disease:1||Liver Abscess:1||Lupus nephritis:1||Lymphocytosis:1||MALDITOF mass spectrometry:1||MLL:1||MLL gene rearrangement:1||MS:1||MYC:1||Macrolideresistant:1||Medical Insurance reimbursement system:1||Medical costs:1||Microbial sensitivity tests:1||Microbiology laboratory:1||Mixed field agglutination:1||Molecular Detection:1||Molecular methods:1||Multidrugresistant:1||Multiplex RT PCR:1||Multiplex realtime PCR:1||Mycobacterium abscessus:1||Mycobacterium terrae:1||Myelodysplastic syndrome:1||Myeloproliferative disorder:1||NGtest Carba 5:1||Nasopharynx:1||Neisseria skkuensis:1||New influenza:1||Nocardia asteroides complex:1||Nocardia farcinica:1||Nocardiosis:1||Nosocomial acquisition:1||Nucleated red blood cells:1||OXA carbapenemase:1||Outbreak:1||PCR/PCRRELF:1||Parainfluenza virus:1||Pediatrics:1||Performance evaluation:1||Peripheral Blood:1||Phenotype:1||Phylogenetic analysis:1||Placentaderived stem cells:1||Plasmacytoid Dendritic Cells:1||Polymerase chain reaction:1||Prednisolone:1||Pseudomonas aeruginosa:1||Psoas muscle:1||Pulmonary:1||Pulsedfield gel electrophoresis (PFGE):1||Purpura fulminans:1||RTPCR:1||Radiologic finding:1||Rapid Diagnostics:1||Rapid antigen test:1||Realtime:1||Realtime PCR:1||Realtime RT PCR:1||Realtime RTPCR:1||Rectal neoplasms:1||RepPCR:1||Respiratory syncytial virus:1||Respiratory tract infection:1||Respiratory tract pathogens:1||Respiratory virus infection:1||Ribotyping:1||Risk factor:1||SARSCoV2 variants:1||ST258:1||Salmonella typhimurium:1||Secondary leukemia:1||Sensitivity:1||Sepsis:1||Sepsityper:1||Septicemia:1||Sequence:1||Serologic marker:1||Species Identification:1||Specificity:1||Specimen collection:1||Splenic marginal zone lymphoma:1||Splenomegaly:1||Streptococcus pneumon:1||Streptococcus pneumoniae:1||Streptococcus pyogenes:1||Survey:1||Therapyrelated ALL:1||Time to detection:1||Turnaroundtime:1||Unexpected antibodies:1||UniCel DxH 800:1||Urine analyzer:1||Urine neutralization test:1||Vancomycinresistant enterococci:1||Viral hepatitis:1||Viral load:1||Virus:1||Wholegenome sequencing:1||Xpert CarbaR:1||Xpert CarbaR assay:1||Yeast:1||action camera:1||adenovirus:1||agreement:1||antibody binding assay:1||antibody test:1||antifungal agents:1||automated hematology analyzer:1||brain abscess:1||cDNA:1||cellular immune responses:1||characterization:1||children:1||clinical feature:1||clinical sensitivity:1||coagulation analyzer:1||combined samples:1||comparison:1||conventional culture:1||crossneutralizing activity:1||cryopreserved RMix ReadyCells:1||cryptic BCR/ABL1 rearrangement:1||dmin:1||empyema:1||feasibility:1||fourth generation immunoassay:1||glycated albumin:1||goPro Hero 4 silver:1||hemagglutininneuraminidase gene:1||hospitalization:1||hsp65:1||hsr:1||human immunodeficiency virus (HIV):1||humoral immune responses:1||immunosuppressants:1||infection:1||influenza A:1||influenza B:1||inv(3)(q21q26):1||itraconazole:1||leukemia:1||linearity:1||lung, biopsy:1||lung, infection:1||malaria:1||malaria antibody:1||mass spectrometry:1||microscopic cell counter:1||mixed infection:1||morbidity:1||multidrug resistant:1||multilocus sequence typing:1||myeloid:1||nasopharyngeal swab:1||neonates:1||neutralizing assay:1||nosocomial infections:1||nucleic acid amplification test:1||opportunistic infections:1||p24 antigen:1||panasonic HXA100:1||parainfluenza virus:1||pneumonia:1||point of care:1||pointofcare testing:1||posaconazole:1||precision correlation:1||program:1||prothrombin time:1||rapid antigen test:1||rapid test kit:1||residual white blood cell:1||respiratory infection:1||respiratory viruses:1||reverse transcriptase PCR:1||rinalysis:1||saliva:1||sensitivity:1||sequencing:1||seroconversion:1||spine surgery:1||sputum:1||standardization:1||surrogate virus neutralization test:1||susceptibility:1||terminology:1||therapeutic drug monitoring:1||therapeutic drug monitoring (TDM):1||trailing growth:1||transfusion:1||tuberculosis, pulmonary:1||vaccination:1||vaccine:1||viral respiratory disease:1||voriconazole:1||감염증:1||관리:1||병원감염:1||분비자 유전자:1||분비자 유전자(Sec2):1||실태조사:1||유세포분석기:1||유전자형:1||유전형:1||임상미생물 검사:1||임상미생물검사:1||임상양상:1||정도관리:1||조사:1||타액의 표현형:1||한국인:1||Acidbase:1||Acinetobacter:1||Acquisition:1||Acute Respiratory Illness:1||Adult:1||Adult stem cells:1||AdvanSure HBV RealTime QPCR:1||AntiSda:1||Antibiotic susceptibility:1||Antibody screening and identification test:1||Antigenemia assay:1||Antimicrobial Susceptibility Testing:1||Antimicrobial susceptibility testing:1||Arbitrarily primed polymerase chain reaction (APPCR):1||Atypical chronic myeloid leukemia:1||B3:1||BACTEC:1||BCRABL1:1||BacT/Alert:1||Baths:1||Blood Culture:1||Bloodstream Infection:1||Bocavirus:1||Body surface area:1||Breast cancer:1||CML:1||COVID19:1||COVID2019:1||Candida albicans:1||Carbapenem:1||Cataract:1||Cefditoren:1||Cellulitis:1||Child:1||Chlorhexidine gluconate:1||Chromogenic culture:1||Clinical severity:1||

STATISTICS: Total View :13,970,157; Today View :18,064

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE